Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes
- DOI
- 10.1016/j.stem.2025.08.012
- Published
- 2025-11
- Container
- Cell Stem Cell
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.stem.2025.08.012,
title = {Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes},
author = {Rajesh C. Rao and Brigitte L. Arduini and Susan Borden and Dhruv Sareen and Clive Svendsen and Paul Lee and Charles Ryan and Shilpa Kodati and Caroline Nyaiburi and Keith Wolsieffer and Eric Oh and Shuna Park and Glenna Ford and Keith Dionne and Sally Temple and Jeffrey Stern},
year = {2025},
journal = {Cell Stem Cell},
doi = {10.1016/j.stem.2025.08.012},
url = {https://doi.org/10.1016/j.stem.2025.08.012}
}RIS
TY - JOUR TI - Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes AU - Rajesh C. Rao AU - Brigitte L. Arduini AU - Susan Borden AU - Dhruv Sareen AU - Clive Svendsen AU - Paul Lee AU - Charles Ryan AU - Shilpa Kodati AU - Caroline Nyaiburi AU - Keith Wolsieffer AU - Eric Oh AU - Shuna Park AU - Glenna Ford AU - Keith Dionne AU - Sally Temple AU - Jeffrey Stern PY - 2025 JO - Cell Stem Cell DO - 10.1016/j.stem.2025.08.012 UR - https://doi.org/10.1016/j.stem.2025.08.012 ER -
APA
Rao, R. C., Arduini, B. L., Borden, S., Sareen, D., Svendsen, C., Lee, P., Ryan, C., Kodati, S., Nyaiburi, C., Wolsieffer, K., Oh, E., Park, S., Ford, G., Dionne, K., Temple, S., & Stern, J. (2025). Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes. Cell Stem Cell. https://doi.org/10.1016/j.stem.2025.08.012
Source records
- crossref · retrieved 2026-09-25T02:33:54.587Z